부산대학교 도서관

Chronic obstructive pulmonary disease (COPD) is a chronic and irreversible respiratory inflammation disease. In 2021, chronic lower respiratory diseases were ranked as the 8th leading cause of death in Taiwan. According to research using the National Health Insurance Research Database, acute exacerbation of COPD has a mortality rate of 4%, results in average annual medical expenses of approximately NT$91,000 per patient, and leads to numerous symptoms and complications. In 2017, the Ministry of Health and Welfare launched the National Health Insurance COPD Medical Payment Improvement Program by the guidelines of the Taiwan Society of Pulmonary and Critical Care Medicine (TSPCCM) and began developing plans for active patient enrollment and treatment. The Joint Commission of Taiwan (JCT) also launched the 'Disease Specific Care- Chronic Obstructive Pulmonary Disease (DSC-COPD)' certification program in 2017 and certified many medical institutions in an effort to improve the quality of COPD care. In this paper, we summarize the series of plans created by the TSPCCM, JCT, and COPD-certified medical institutions that can be used to develop a combined care and treatment model for COPD.